Current market dynamics in the European life sciences sector have been radically altered by the turbulence of COVID-19. The pandemic, however, has presented unique challenges and opportunities - Magazine Article - PharmaTimes
The COVID-19 pandemic created many uncertainties and challenges for investors and operators alike across the Middle East, including in the United Arab Emirates, which is often considered a regional healthcare and business hub. As a result, 2020 saw many transactions in the healthcare sector either abandoned or put on hold, but the region has since demonstrated signs of a strong recovery in the transactional space in general and particularly in the healthcare industry.